Predict your next investment

Corporation
HEALTHCARE | Drug Development
arvelletx.com

See what CB Insights has to offer

Founded Year

2019

Stage

Acquired | Acquired

Total Raised

$207.8M

Valuation

$0000 

About Arvelle Therapeutics

Arvelle Therapeutics seeks to bring CNS products to patients suffering from neurological conditions.On January 4th, 2021, Arvelle Therapeutics was acquired by Angelini Pharma at a valuation of $960M.

Arvelle Therapeutics Headquarter Location

Zählerweg 6

Zug, 6300,

Switzerland

888-317-1041

Latest Arvelle Therapeutics News

NICE recommends Angelini’s Ontozry for the treatment of focal-onset seizures

Nov 15, 2021

Switzerland-based Arvelle Therapeutics, which was acquired by Italy’s Angelini earlier this year, today… To continue reading The Pharma Letter please login ,   subscribe  or  claim a 7 day free trial subscription  and access exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space. Or, if you're only interested in reading the content about a specific topic (M&A, coronavirus/COVID-19, pricing, reimbursement and access, outsourcing, CRO and CMO, and regulation), then you can take our £10 per month channel subscription offer, which gives you access to all our news articles and in-depth content on this subject.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Arvelle Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Arvelle Therapeutics is included in 1 Expert Collection, including Biopharmaceuticals.

B

Biopharmaceuticals

5,882 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Arvelle Therapeutics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Arvelle Therapeutics Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.